- Home
- PLNT vs HALO Comparison
PLNT vs HALO Comparison
Compare PLNT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLNT
- HALO
- Stock Information
- Founded
- PLNT 1992
- HALO 1998
- Country
- PLNT United States
- HALO United States
- Employees
- PLNT N/A
- HALO N/A
- Industry
- PLNT Hotels/Resorts
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLNT Consumer Discretionary
- HALO Health Care
- Exchange
- PLNT Nasdaq
- HALO Nasdaq
- Market Cap
- PLNT 8.1B
- HALO 7.4B
- IPO Year
- PLNT 2015
- HALO N/A
- Fundamental
- Price
- PLNT $93.80
- HALO $66.58
- Analyst Decision
- PLNT Buy
- HALO Buy
- Analyst Count
- PLNT 17
- HALO 9
- Target Price
- PLNT $102.76
- HALO $63.78
- AVG Volume (30 Days)
- PLNT 1.5M
- HALO 2.1M
- Earning Date
- PLNT 05-08-2025
- HALO 05-06-2025
- Dividend Yield
- PLNT N/A
- HALO N/A
- EPS Growth
- PLNT 21.55
- HALO 55.40
- EPS
- PLNT 2.11
- HALO 3.76
- Revenue
- PLNT $1,129,218,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- PLNT $20.79
- HALO $20.06
- Revenue Next Year
- PLNT $9.98
- HALO $24.20
- P/E Ratio
- PLNT $44.60
- HALO $17.71
- Revenue Growth
- PLNT 10.26
- HALO 25.64
- 52 Week Low
- PLNT $59.16
- HALO $41.28
- 52 Week High
- PLNT $110.00
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- PLNT 44.77
- HALO 60.23
- Support Level
- PLNT $92.78
- HALO $58.38
- Resistance Level
- PLNT $102.92
- HALO $69.94
- Average True Range (ATR)
- PLNT 3.15
- HALO 2.71
- MACD
- PLNT -0.14
- HALO 0.84
- Stochastic Oscillator
- PLNT 14.11
- HALO 69.44
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.